Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells
Molecules · 2023
DOI: 10.3390/molecules28031476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Sou Hyun Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PNU-RENovation.
Abstract (Originalsprache)
Liver metabolic disorders and oxidative stress are crucial factors in the development of nonalcoholic fatty liver disease (NAFLD); however, treatment strategies to combat NAFLD remain poorly established, presenting an important challenge that needs to be addressed. Herein, we aimed to examine the effect of isoquercitrin on lipid accumulation induced by exogenous free fatty acids (FFA) using HepG2 cells and elucidate the underlying molecular mechanism. The cells were exposed to 0.5 mM FFA to induce intracellular lipid accumulation, followed by co-treatment with isoquercitrin to confirm the potential inhibitory effect on FFA-induced lipid production. HepG2 cells exposed to FFA alone exhibited intracellular lipid accumulation, compromised endoplasmic reticulum (ER) stress, and enhanced expression of proteins and genes involved in lipid synthesis; however, co-treatment with isoquercitrin decreased the expression of these molecules in a dose-dependent manner. Furthermore, isoquercitrin could activate AMP-activated protein kinase (AMPK), a key regulatory protein of hepatic fatty acid oxidation, suppressing new lipid production by phosphorylating acetyl-CoA carboxylase (ACC) and inhibiting sterol regulatory element-binding transcription factor 1 (SREBP-1)/fatty acid synthase (FAS) signals. Overall, these findings suggest that isoquercitrin can be employed as a therapeutic agent to improve NAFLD via the regulation of lipid metabolism by targeting the AMPK/ACC and SREBP1/FAS pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.
- College of Pharmacy, Jeju Research Institute of Pharmaceutical Sciences, Jeju National University, Jeju 63243, Republic of Korea.
- College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea.
- College of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
ORCID-Profile: Sou Hyun Kim, Chawon Yun, Yun-Hee Lee, Jae-Hwan Kwak, Young-Suk Jung
Förderung
- PNU-RENovation
Zitieren
APA
Kim, S. H., Yun, C., Kwon, D., Lee, Y. H., Kwak, J. H., & Jung, Y. S. (2023). Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells. Molecules. https://doi.org/10.3390/molecules28031476
Vancouver
Kim SH, Yun C, Kwon D, Lee YH, Kwak JH, Jung YS. Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells. Molecules. 2023. doi:10.3390/molecules28031476
BibTeX
@article{Kim2023,
author = {Kim, Sou Hyun and Yun, Chawon and Kwon, Doyoung and Lee, Yun-Hee and Kwak, Jae-Hwan and Jung, Young-Suk},
title = {Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28031476}
}
EUVIMED